Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANRENONE vs CAPLACIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANRENONE vs CAPLACIZUMAB: Safety Overview

Metric CANRENONE CAPLACIZUMAB
Total FAERS Reports 286 145
Deaths Reported 19 34
Death Rate 6.6% 23.4%
Hospitalizations 199 53
Average Patient Age 69.0 yrs 53.0 yrs
% Female Patients 51.8% 51.2%
Manufacturer N/A Genzyme Corporation